SCHEMBL16401328

SCHEMBL16401328

C=CCCCC[C@](C)(N)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ARG1 P05089 3/20 0.55
ARG2 P78540 3/20 0.55
GGT1 P19440 1/20 0.46
ACLY P53396 1/20 0.44
MAPT P10636 2/20 0.44
ABCC4 O15439 1/20 0.44
ALDH1A1 P00352 3/20 0.39
LMNA P02545 2/20 0.39
TSHR P16473 2/20 0.35
BLM P54132 1/20 0.33
GRM2 Q14416 1/20 0.33
FFAR1 O14842 1/20 0.32
CPT2 P23786 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
USP2 O75604 1/20 0.32
CYP3A4 P08684 1/20 0.32
RECQL P46063 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
ACACB O00763 1/20 0.32
ACACA Q13085 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19305277 1.00 ARG1 (0.55) ARG1ARG2GGT1ACLYMAPT
SCHEMBL18954910 1.00 ARG1 (0.55) ARG1ARG2GGT1ACLYMAPT
SCHEMBL16401653 1.00 ARG1 (0.55) ARG1ARG2GGT1ACLYMAPT
SCHEMBL1975910 0.98 ARG1 (0.53) ARG1ARG2GGT1ACLYMAPT
SCHEMBL1975908 0.98 ARG1 (0.53) ARG1ARG2GGT1ACLYMAPT
SCHEMBL19357334 0.98 ARG1 (0.53) ARG1ARG2GGT1ACLYMAPT
SCHEMBL18954850 0.98 ARG1 (0.53) ARG1ARG2GGT1ACLYMAPT
SCHEMBL22862319 0.98 ARG1 (0.53) ARG1ARG2GGT1ACLYMAPT
SCHEMBL19305278 0.98 ARG1 (0.53) ARG1ARG2GGT1ACLYMAPT
SCHEMBL18954854 0.98 ARG1 (0.53) ARG1ARG2GGT1ACLYMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3280431-B1 DISRUPTION OF THE WAVE3 PROTEIN COMPLEX FOR SUPPRESSION OF INVASION AND METASTASIS UNIV GEORGIA (US) 2023-11-08 EP disclosed
US-11773146-B2 Disruption of the WAVE3 protein complex for suppression of invasion and metastasis UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2023-10-03 US disclosed
US-20230220019-A1 CHEMICALLY-STABILIZED ALLOSTERIC MODULATORS OF LEUCINERICH REPEAT KINASE 2 (LRRK2) UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. 2023-07-13 US disclosed
US-11299518-B2 Fusion respiratory syncytial virus inhibitors and use thereof FONDATION THE ARK (CH) 2022-04-12 US disclosed
US-20210024595-A1 DISRUPTION OF THE WAVE3 PROTEIN COMPLEX FOR SUPPRESSION OF INVASION AND METASTASIS UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. 2021-01-28 US disclosed
US-10822380-B2 Disruption of the WAVE3 protein complex for suppression of invasion and metastasis UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2020-11-03 US disclosed
US-20180362587-A1 Compositions and Methods for Inhibiting CBP80 Binding to PGC1 Family of Co-Activators UNIVERSITY OF ROCHESTER 2018-12-20 US disclosed
US-20180072782-A1 DISRUPTION OF THE WAVE3 PROTEIN COMPLEX FOR SUPPRESSION OF INVASION AND METASTASIS AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC. 2018-03-15 US disclosed
EP-3280431-A1 DISRUPTION OF THE WAVE3 PROTEIN COMPLEX FOR SUPPRESSION OF INVASION AND METASTASIS University of Georgia Research Foundation Inc. (US) 2018-02-14 EP disclosed
WO-2017099821-A1 COMPOSITIONS AND METHODS FOR INHIBITING CBP80 BINDING TO PGCI FAMILY OF CO-ACTIVATORS UNIVERSITY OF ROCHESTER (US) 2017-06-15 WO disclosed
WO-2016164768-A1 DISRUPTION OF THE WAVE3 PROTEIN COMPLEX FOR SUPPRESSION OF INVASION AND METASTASIS UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2016-10-13 WO disclosed
WO-2015010048-A1 CHEMICALLY-STABILIZED A KINASE ANCHORING PROTEIN (AKAP) PEPTIDE DISRUPTORS UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2015-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230220019-A1 CHEMICALLY-STABILIZED ALLOSTERIC MODULATORS OF LEUCINERICH REPEAT KINASE 2 (LRRK2) LRRK2, TLK2, LMTK2 ARG1 4424/4885ARG2 3024/4885GGT1 1852/4885
US-20180362587-A1 Compositions and Methods for Inhibiting CBP80 Binding to PGC1 Family of Co-Activators CREB1, NCOA1, CREBBP ARG1 378/4885ARG2 680/4885GGT1 1360/4885
US-11299518-B2 Fusion respiratory syncytial virus inhibitors and use thereof BST2, TMPRSS4, TMPRSS2 ARG1 1590/4885ARG2 1157/4885GGT1 1241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.